semaglutide compounding pharmacy ban States cracking down on pharmacies selling knockoff weight-loss drugs Pharmacies making copycat Ozempic could

Wegovy, a higher-dose formulation of semaglutide, is specifically approved for weight management

Eli Lilly and Company 's Retatrutide Shows Up to 28% Weight Loss in Phase-3 Study Eli Lilly reported promising Phase-3 results for #retatrutide, with the triple agonist therapy demonstrating up to 28% weight loss, marking a major milestone in next-generation obesity treatment innovation

Natural Sweeteners Like Allulose: Supporting GLP-1 Without Spiking Blood Sugar Pro Tip: Allulose, a low-glycemic sweetener, doesnt cause significant blood sugar spikes and may support GLP-1 production

Since each state has different rules, its wise to check your states laws or consult a lawyer to ensure you understand your deadlines and protect your rights